Olga Perski1, Emily T Hébert2, Felix Naughton3, Eric B Hekler4,5, Jamie Brown1, Michael S Businelle6. 1. Department of Behavioural Science and Health, University College London, London, UK. 2. University of Texas Health Science Center (UTHealth) School of Public Health, Austin, TX, USA. 3. Behavioural and Implementation Science Group, School of Health Sciences, University of East Anglia, Norwich, UK. 4. Herbert Wertheim School of Public Health and Human Longevity (HWSPH), University of California at San Diego, La Jolla, CA, USA. 5. Center for Wireless and Population Health Systems (CWPHS), Qualcomm Institute and HWSPH, University of California at San Diego, La Jolla, CA, USA. 6. TSET Health Promotion Research Center, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Abstract
BACKGROUND AND AIMS: Lapse risk when trying to stop or reduce harmful substance use is idiosyncratic, dynamic and multi-factorial. Just-in-time adaptive interventions (JITAIs) aim to deliver tailored support at moments of need or opportunity. We aimed to synthesize evidence on decision points, tailoring variables, intervention options, decision rules, study designs, user engagement and effectiveness of technology-mediated JITAIs for reducing harmful substance use. METHODS: Systematic review of empirical studies of any design with a narrative synthesis. We searched Ovid MEDLINE, Embase, PsycINFO, Web of Science, the ACM Digital Library, the IEEE Digital Library, ClinicalTrials.gov, the ISRCTN register and dblp using terms related to substance use/mHealth/JITAIs. Outcomes were user engagement and intervention effectiveness. Study quality was assessed with the mHealth Evidence Reporting and Assessment checklist. FINDINGS: We included 17 reports of 14 unique studies, including two randomized controlled trials. JITAIs targeted alcohol (S = 7, n = 120 520), tobacco (S = 4, n = 187), cannabis (S = 2, n = 97) and a combination of alcohol and illicit substance use (S = 1, n = 63), and primarily relied on active measurement and static (i.e. time-invariant) decision rules to deliver support tailored to micro-scale changes in mood or urges. Two studies used data from prior participants and four drew upon theory to devise decision rules. Engagement with available JITAIs was moderate-to-high and evidence of effectiveness was mixed. Due to substantial heterogeneity in study designs and outcome variables assessed, no meta-analysis was performed. Many studies reported insufficient detail on JITAI infrastructure, content, development costs and data security. CONCLUSIONS: Current implementations of just-in-time adaptive interventions (JITAIs) for reducing harmful substance use rely on active measurement and static decision rules to deliver support tailored to micro-scale changes in mood or urges. Studies on JITAI effectiveness are lacking.
BACKGROUND AND AIMS: Lapse risk when trying to stop or reduce harmful substance use is idiosyncratic, dynamic and multi-factorial. Just-in-time adaptive interventions (JITAIs) aim to deliver tailored support at moments of need or opportunity. We aimed to synthesize evidence on decision points, tailoring variables, intervention options, decision rules, study designs, user engagement and effectiveness of technology-mediated JITAIs for reducing harmful substance use. METHODS: Systematic review of empirical studies of any design with a narrative synthesis. We searched Ovid MEDLINE, Embase, PsycINFO, Web of Science, the ACM Digital Library, the IEEE Digital Library, ClinicalTrials.gov, the ISRCTN register and dblp using terms related to substance use/mHealth/JITAIs. Outcomes were user engagement and intervention effectiveness. Study quality was assessed with the mHealth Evidence Reporting and Assessment checklist. FINDINGS: We included 17 reports of 14 unique studies, including two randomized controlled trials. JITAIs targeted alcohol (S = 7, n = 120 520), tobacco (S = 4, n = 187), cannabis (S = 2, n = 97) and a combination of alcohol and illicit substance use (S = 1, n = 63), and primarily relied on active measurement and static (i.e. time-invariant) decision rules to deliver support tailored to micro-scale changes in mood or urges. Two studies used data from prior participants and four drew upon theory to devise decision rules. Engagement with available JITAIs was moderate-to-high and evidence of effectiveness was mixed. Due to substantial heterogeneity in study designs and outcome variables assessed, no meta-analysis was performed. Many studies reported insufficient detail on JITAI infrastructure, content, development costs and data security. CONCLUSIONS: Current implementations of just-in-time adaptive interventions (JITAIs) for reducing harmful substance use rely on active measurement and static decision rules to deliver support tailored to micro-scale changes in mood or urges. Studies on JITAI effectiveness are lacking.
Authors: Matthew D Koslovsky; Emily T Hébert; Michael D Swartz; Wenyaw Chan; Luis Leon-Novelo; Anna V Wilkinson; Darla E Kendzor; Michael S Businelle Journal: Nicotine Tob Res Date: 2018-09-04 Impact factor: 4.244
Authors: Bettina B Hoeppner; Susanne S Hoeppner; Melissa R Schick; Connor M Milligan; Eric Helmuth; Brandon G Bergman; Lorien C Abroms; John F Kelly Journal: Subst Use Misuse Date: 2019-04-19 Impact factor: 2.164
Authors: Predrag Klasnja; Eric B Hekler; Saul Shiffman; Audrey Boruvka; Daniel Almirall; Ambuj Tewari; Susan A Murphy Journal: Health Psychol Date: 2015-12 Impact factor: 4.267
Authors: Michael S Businelle; Cho Y Lam; Darla E Kendzor; Ludmila Cofta-Woerpel; Jennifer B McClure; Paul M Cinciripini; David W Wetter Journal: Exp Clin Psychopharmacol Date: 2013-02 Impact factor: 3.157
Authors: Scott T Walters; Eun-Young Mun; Zhengqi Tan; Justin M Luningham; Emily T Hébert; Jason A Oliver; Michael S Businelle Journal: Alcohol Clin Exp Res Date: 2022-08-07 Impact factor: 3.928
Authors: Lizbeth Benson; Chaelin K Ra; Emily T Hébert; Darla E Kendzor; Jason A Oliver; Summer G Frank-Pearce; Jordan M Neil; Michael S Businelle Journal: Front Digit Health Date: 2022-03-29
Authors: Andy Wai Kan Yeung; Stefan Tino Kulnik; Emil D Parvanov; Anna Fassl; Fabian Eibensteiner; Sabine Völkl-Kernstock; Maria Kletecka-Pulker; Rik Crutzen; Johanna Gutenberg; Isabel Höppchen; Josef Niebauer; Jan David Smeddinck; Harald Willschke; Atanas G Atanasov Journal: J Med Internet Res Date: 2022-05-11 Impact factor: 7.076